VIRADAY TABLET 30'S

Viraday Tablet is often combined with other antiretroviral medications as part of a multidrug regimen for treating HIV infection. The specific combination of medications will depend on individual health status, treatment history, and potential drug interactions.

Viraday Tablet can be used in older adults. Still, dosage adjustments or additional monitoring may be necessary, as age-related changes in kidney and liver function can affect medication clearance. It is important to discuss individual health status and any concerns with a healthcare provider.

Individuals with pre-existing bone conditions, such as osteoporosis or osteopenia, may require careful monitoring and management when using Viraday Tablet. It is important to discuss any underlying bone conditions with your healthcare provider to ensure appropriate bone health monitoring and potential supplementation.

Viraday Tablet, when used as PrEP, significantly reduces the risk of HIV transmission through sexual activity or injection drug use. However, they do not provide 100% protection against HIV, and it is important to continue practicing safe sex and taking other preventive measures.

Although rare, Viraday Tablet has been associated with the risk of lactic acidosis. Lactic acidosis is a serious condition characterized by the accumulation of lactic acid in the blood. It is important to promptly report any symptoms such as unusual weakness, rapid breathing, nausea, vomiting, abdominal pain, or unexplained muscle pain to your healthcare provider while taking it.

Monitoring of bone mineral density may be recommended for individuals on long-term treatment with Tenofovir disoproxil fumarate. Your healthcare provider may request bone density scans or blood tests to assess bone health and determine if any interventions or additional treatments are necessary.

Viraday Tablets should be used cautiously in individuals with liver or kidney impairment. Dose adjustments or alternative treatment options may be necessary.

It is important to discuss all medications you are taking with your doctor, as VIRADAY TABLET 30'S may interact with other drugs. Your doctor can advise on potential interactions and necessary adjustments.

Important risks and warnings include potential issues during pregnancy and breastfeeding, and the need for cautious use and monitoring in individuals with pre-existing liver disease, kidney disease, or bone disorders. Always discuss your medical history and concerns with your healthcare provider.

VIRADAY TABLET 30'S contains EFAVIRENZ, EMTRICITABINE, and TENOFOVIR DISOPROXIL FUMARATE.

VIRADAY TABLET 30'S is used for the treatment of Antiviral conditions, specifically HIV/AIDS.